BiotechTube

Placebo + Prednisolone

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Insulin Resistance

Conditions

Insulin Resistance, Hyperglycemia, Glucose Intolerance

Trial Timeline

May 1, 2006 → Mar 1, 2008

NCT ID
NCT00971724

About Placebo + Prednisolone

Placebo + Prednisolone is a pre-clinical stage product being developed by Merck for Insulin Resistance. The current trial status is completed. This product is registered under clinical trial identifier NCT00971724. Target conditions include Insulin Resistance, Hyperglycemia, Glucose Intolerance.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT00971724Pre-clinicalCompleted

Competing Products

20 competing products in Insulin Resistance

See all competitors
ProductCompanyStageHype Score
naveglitazarEli LillyPhase 2
52
AC2993 + AC2993 + Placebo + PlaceboAstraZenecaPhase 3
77
Dapagliflozin 10 mg + Placebo tabletAstraZenecaPhase 3
77
Placebo 0.01 mL + Placebo 0.02 mL + Placebo 0.03 mL + Placebo 0.04 mL + AC2993 2.5 mcg + AC2993 5.0 mcg + AC2993 7.5 mcg + AC2993 10.0 mcgAstraZenecaPhase 2
52
Atropine + Physostigmine + Placebo SodiumAstraZenecaPhase 1
33
SaxagliptinAstraZenecaApproved
85
AC2993 + AC2993 + Placebo + PlaceboAstraZenecaPhase 3
77
Pramlintide acetateAstraZenecaPhase 2
52
sitagliptin + Comparator: glimepiride + open-label metforminMerckPhase 3
77
sitagliptinMerckApproved
85
sitagliptin phosphateMerckPhase 3
77
MK-1006 + PlaceboMerckPhase 1
33
Comparator: Placebo + Sitagliptin + VogliboseMerckPhase 3
77
sitagliptin phosphate + Comparator: metformin + Comparator: metformin + Comparator: Antidiabetic Standard of CareMerckPhase 3
77
Placebo + MK-0941MerckPhase 1
33
Comparator: exenatide + Comparator: exenatide + Comparator: PlaceboMerckPhase 1
33
simvastatin/ezetimibe + atorvastatin 20mgMerckApproved
85
sitagliptin phosphate + Comparator: Placebo + Comparator: SitagliptinMerckPhase 2
52
sitagliptin phosphateMerckPhase 1
33
sitagliptin phosphate + Comparator: vogliboseMerckPhase 3
77

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85